loader
Please Wait
Applying Filters...

Bora CDMO Bora CDMO

X

List of All Manufacturers & Suppliers for 2474875 Licensing, EU CTD Dossiers, Marketing Authorizations, Finished Dosage Formulations listed on PharmaCompass.com

Client Virtual Booth
Menu
Filters Filter
Cross PopUp
FILTER :

filter

01 INSULIN DEGLUDEC (1)

02 LIRAGLUTIDE (1)

filter

01 NOVO NORDISK CANADA INC (2)

filter

01 SOLUTION (2)

filter

01 100UNIT/ML (1)

02 3.6MG/ML (1)

filter

01 Canada (2)

URL Supplier Web Content
SOLUTION
3.6MG/ML
XULTOPHY
Canada
2474875
1X3ML/3X3ML/5X3ML
Prescription
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
SOLUTION
100UNIT/ML
XULTOPHY
Canada
2474875
1X3ML/3X3ML/5X3ML
Prescription
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Looking for CTD TGA MCC DOSSIER APPLICATION 2474875

Looking for CTD TGA MCC DOSSIER APPLICATION 2474875 2

19

Novo Nordisk, based in Denmark, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.

One of their notable products is LIRAGLUTIDE, with a corresponding application number 2474875 and regulatory information .

proudly manufactured in the

Novo Nordisk's XULTOPHY SOLUTION, medication with 3.6MG/ML of LIRAGLUTIDE.

18

Novo Nordisk, based in Denmark, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.

One of their notable products is INSULIN DEGLUDEC, with a corresponding application number 2474875 and regulatory information .

proudly manufactured in the

Novo Nordisk's XULTOPHY SOLUTION, medication with 100UNIT/ML of INSULIN DEGLUDEC.

Post Enquiry
POST ENQUIRY